Cargando…
Optimization of a nicotine degrading enzyme for potential use in treatment of nicotine addiction
BACKGROUND: Smoking and tobacco use continue to be the largest preventable causes of death globally. A novel therapeutic approach has recently been proposed: administration of an enzyme that degrades nicotine, the main addictive component of tobacco, minimizing brain exposure and reducing its reinfo...
Autores principales: | Thisted, Thomas, Biesova, Zuzana, Walmacq, Celine, Stone, Everett, Rodnick-Smith, Max, Ahmed, Shaheda S., Horrigan, Stephen K., Van Engelen, Bo, Reed, Charles, Kalnik, Matthew W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679477/ https://www.ncbi.nlm.nih.gov/pubmed/31375100 http://dx.doi.org/10.1186/s12896-019-0551-5 |
Ejemplares similares
-
The nicotine-degrading enzyme NicA2 reduces nicotine levels in blood, nicotine distribution to brain, and nicotine discrimination and reinforcement in rats
por: Pentel, Paul R., et al.
Publicado: (2018) -
Attenuating nicotine’s effects with high affinity human anti-nicotine monoclonal antibodies
por: Raleigh, Michael D., et al.
Publicado: (2021) -
Nicotinic activation of laterodorsal tegmental neurons: implications for addiction to nicotine
por: Ishibashi, Masaru, et al.
Publicado: (2009) -
Nicotine Addiction: Neurobiology and Mechanism
por: Tiwari, Raj Kumar, et al.
Publicado: (2020) -
Insights into Nicotinic Receptor Signaling in Nicotine Addiction: Implications for Prevention and Treatment
por: Liu, Wuyi, et al.
Publicado: (2018)